Skip to content
value.today

Egg Medical, Inc.

Total raised
$28 M
4 rounds on record
Latest round
$10 M
Jun 2026
First round on record
Feb 2022
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Egg Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2026$10 MNo. 4$2 to $10 million

Egg Medical, Inc.: Raise no. 4, Jun 2026

Investors in this round

10 investors had bought by the notice of Jun 12, 2026: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $13 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gavin P. Philipps · Executive Officer
  • John P. Gainor · Executive Officer, Director
  • Robert F. Wilson · Executive Officer, Director
  • Scott P. Youngstrom · Executive Officer
  • Luc P. Marengere · Director
  • Marc P. Riviere · Director
  • Uma F. Valeti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Scott P. Youngstrom, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 12, 2026. Read the notice at the SEC.

equitySEC
Jan 2025$10 MNo. 3$2 to $10 million

Egg Medical, Inc.: Raise no. 3, Jan 2025

Investors in this round

20 investors had bought by the notice of Feb 5, 2025: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Conversion of Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert F. Wilson · Executive Officer, Director
  • John P. Gainor · Director
  • Luc P. Marengere · Director
  • Marc P. Riviere · Director
  • Uma F. Valeti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert F. Wilson, M.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 5, 2025. Read the notice at the SEC.

equitySEC
Jan 2024$3 MNo. 2$2 to $10 million

Egg Medical, Inc.: Raise no. 2, Jan 2024

Investors in this round

1 investor had bought by the notice of Jan 26, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert F. Wilson · Executive Officer, Director
  • Luc F. Marengere · Director
  • Sascha F. Berger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert F. Wilson, M.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 26, 2024. Read the notice at the SEC.

equity, debtSEC
Feb 2022$6 MNo. 1$2 to $10 million

Egg Medical, Inc.: Raise no. 1, Feb 2022

Investors in this round

1 investor had bought by the notice of Feb 28, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $13 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John F. Gainor · Executive Officer, Director
  • Robert F. Wilson · Executive Officer, Director
  • Scott P. Youngstrom · Executive Officer
  • Uma F. Valeti · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert F. Wilson, President and CEO. Source: SEC Form D, newest notice filed Feb 28, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Egg Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2026

That is all the official record says: Egg Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Egg Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Egg Medical, Inc.
NameRoleNamed in
Gavin P. PhilippsExecutive officerJun 2026
John P. GainorExecutive officerJun 2026
Robert F. WilsonExecutive officerJun 2026
Scott P. YoungstromExecutive officerJun 2026
John F. GainorExecutive officerFeb 2022
Uma F. ValetiExecutive officerFeb 2022
John P. GainorDirectorJun 2026
Luc P. MarengereDirectorJun 2026
Marc P. RiviereDirectorJun 2026
Robert F. WilsonDirectorJun 2026
Uma F. ValetiDirectorJun 2026
Luc F. MarengereDirectorJan 2024
Sascha F. BergerDirectorJan 2024
John F. GainorDirectorFeb 2022